Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Telesis Bio Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS
Ticker
Exchange
SIC #
Website
Latest Ticker
TBIO
Nasdaq
3826
https://telesisbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Telesis Bio Inc
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 28th, 2024 8:05 pm
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
- Feb 26th, 2024 2:15 pm
Telesis Bio Reports Third Quarter 2023 Financial Results
- Nov 13th, 2023 9:22 pm
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
- Nov 7th, 2023 2:00 pm
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
- Nov 3rd, 2023 4:00 pm
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
- Sep 28th, 2023 7:48 pm
This Telesis Bio Insider Increased Their Holding In The Last Year
- Sep 5th, 2023 10:42 am
Telesis Bio Appoints William J. Kullback Chief Financial Officer
- Aug 29th, 2023 8:05 pm
Telesis Bio Reports Second Quarter 2023 Financial Results
- Aug 10th, 2023 8:05 pm
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
- Aug 3rd, 2023 9:00 pm
Telesis Bio to Present at Jefferies Healthcare Conference 2023
- Jun 8th, 2023 1:05 pm
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
- Jun 6th, 2023 7:00 am
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
- Jun 5th, 2023 9:30 pm
Telesis Bio Secures Financing of $28.0 Million
- May 31st, 2023 9:29 pm
Telesis Bio to Present at SynBioBeta 2023
- May 23rd, 2023 1:00 pm
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
- May 22nd, 2023 4:00 pm
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
- May 18th, 2023 2:00 pm
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
- May 15th, 2023 1:00 pm
Telesis Bio First Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag
- May 13th, 2023 12:05 pm
Telesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates
- May 11th, 2023 9:25 pm
Scroll